tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Amsellem, 231 are a BUY (73.1%), 74 are a HOLD (23.42%), 11 are a SELL (3.48%).
Analyst David Amsellem works at PIPER SANDLER with a stock forecast success ratio of 51.12% fulfilled within 203.57 days on average.
David Amsellem’s has documented 640 price targets and ratings displayed on 37 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALKS, Alkermes Plc at 01-Apr-2024.
Analyst best performing recommendations are on REPH (RECRO PHARMA).
The best stock recommendation documented was for HZNP (HORIZON PHARMA PLC) at 12/7/2022. The price target of $110 was fulfilled within 5 days with a profit of $13.7 (14.23%) receiving and performance score of 28.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2 years 5 months ago
0/1 (0%)
$34.88 (99.32%)
Hold
14
2 years 6 months 4 days ago
3/7 (42.86%)
$9.25 (194.74%)
87
Hold
7
$-1.22 (-14.84%)
7
2 years 6 months 5 days ago
3/8 (37.5%)
$-1.08 (-13.37%)
124
Buy
9.1
$0.88 (10.71%)
12
2 years 6 months 5 days ago
0/7 (0%)
$1.02 (12.62%)
Buy
6
$-2.22 (-27.01%)
20
2 years 6 months 5 days ago
0/2 (0%)
$3.2 (23.94%)
Which stock is David Amsellem is most bullish on?
Which stock is David Amsellem is most reserved on?
What Year was the first public recommendation made by David Amsellem?
